114 related articles for article (PubMed ID: 16554946)
1. Structural neuroimaging outcomes in clinical dementia trials, with special reference to disease modifying designs.
Scheltens P; Barkhof F
J Nutr Health Aging; 2006; 10(2):123-8; discussion 129-30. PubMed ID: 16554946
[TBL] [Abstract][Full Text] [Related]
2. Advances in the early detection of Alzheimer's disease.
Nestor PJ; Scheltens P; Hodges JR
Nat Med; 2004 Jul; 10 Suppl():S34-41. PubMed ID: 15298007
[TBL] [Abstract][Full Text] [Related]
3. Defining and labeling disease-modifying treatments for Alzheimer's disease.
Cummings JL
Alzheimers Dement; 2009 Sep; 5(5):406-18. PubMed ID: 19751920
[TBL] [Abstract][Full Text] [Related]
4. Scales as outcome measures for Alzheimer's disease.
Black R; Greenberg B; Ryan JM; Posner H; Seeburger J; Amatniek J; Resnick M; Mohs R; Miller DS; Saumier D; Carrillo MC; Stern Y
Alzheimers Dement; 2009 Jul; 5(4):324-39. PubMed ID: 19560103
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers in Alzheimer's disease: not yet surrogate endpoints.
Coley N; Andrieu S; Delrieu J; Voisin T; Vellas B
Ann N Y Acad Sci; 2009 Oct; 1180():119-24. PubMed ID: 19906266
[TBL] [Abstract][Full Text] [Related]
6. Role of cognitive testing in disease modifying AD trials.
Visser PJ
J Nutr Health Aging; 2006; 10(2):131-2; discussion 132-3. PubMed ID: 16554947
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers in preclinical Alzheimer's disease.
Chong MS; Lim WS; Sahadevan S
Curr Opin Investig Drugs; 2006 Jul; 7(7):600-7. PubMed ID: 16869111
[TBL] [Abstract][Full Text] [Related]
8. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?
Gauthier S; Poirier J
Alzheimers Dement; 2009 Mar; 5(2):147-8. PubMed ID: 19328447
[No Abstract] [Full Text] [Related]
9. Diagnostic imaging devices in Alzheimer's disease.
Jelic V; Wahlund LO
Expert Rev Med Devices; 2007 Jul; 4(4):475-87. PubMed ID: 17605683
[TBL] [Abstract][Full Text] [Related]
10. Binswanger's disease or artifact: a clinical, neuroimaging, and pathological study of periventricular white matter changes in Alzheimer's disease.
Morris JC; Gado M; Torack RM; McKeel DW
Adv Neurol; 1990; 51():47-52. PubMed ID: 2294663
[No Abstract] [Full Text] [Related]
11. Magnetic resonance analysis of amygdalar volume in Alzheimer's disease.
Horínek D; Varjassyová A; Hort J
Curr Opin Psychiatry; 2007 May; 20(3):273-7. PubMed ID: 17415082
[TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment no dementia - neuropsychological and neuroimaging characterization of an amnestic subgroup.
Jacova C; Peters KR; Beattie BL; Wong E; Riddehough A; Foti D; Scheltens P; Li DK; Feldman HH
Dement Geriatr Cogn Disord; 2008; 25(3):238-47. PubMed ID: 18264009
[TBL] [Abstract][Full Text] [Related]
13. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
Meyer JS; Huang J; Chowdhury MH
J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction.
Henry-Feugeas MC
Med Hypotheses; 2008; 70(4):866-75. PubMed ID: 17825499
[TBL] [Abstract][Full Text] [Related]
15. Diffusion tensor MRI to investigate dementias: a brief review.
Bozzali M; Cherubini A
Magn Reson Imaging; 2007 Jul; 25(6):969-77. PubMed ID: 17451903
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
[TBL] [Abstract][Full Text] [Related]
17. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
Giovagnoli AR; Erbetta A; Reati F; Bugiani O
Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
[TBL] [Abstract][Full Text] [Related]
18. Recommendations concerning neuropsychiatric symptoms assessment.
Verhey F
J Nutr Health Aging; 2006; 10(2):134-5; discussion 135-6. PubMed ID: 16554948
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
20. A computational method for the estimation of atrophic changes in Alzheimer's disease and mild cognitive impairment.
Fritzsche KH; von Wangenheim A; Abdala DD; Meinzer HP
Comput Med Imaging Graph; 2008 Jun; 32(4):294-303. PubMed ID: 18343635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
